Successful treatment of recurrent primary central nervous system lymphoma with high‐dose methotrexate

Cancer

Volumn 45, Issue 7, 1980, Pages 1556-1557

  Ervin, Thomas ^a,b   Canellos, George P ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DRUG DOSE; DRUG THERAPY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NERVOUS SYSTEM; NEUROSURGERY; PLASMACYTOMA; RADIOTHERAPY; THERAPY;

CASE REPORT; CEREBELLAR NEOPLASMS; FEMALE; HUMAN; LYMPHOMA; METHOTREXATE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018842103     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19800401)45:7<1556::AID-CNCR2820450707>3.0.CO;2-B     Document Type: Article

References (11)

1. Occurrence and prognosis of extranodal lymphomas
2. Primary malignant lymphomas of the central nervous system
3. Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system
4. Lymphoproliferative disorders in organ transplant recipients
5. Reticulum sarcoma of the brain
6. High‐dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children
7. Methotrexate: Distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections
8. High‐dose methotrexate with folinic acid rescue in the treatment of advanced non‐Hodgkin's lymphoma including CNS involvement
9. Clinical pharmacology of high‐dose methotrexate
10. An immunohistological study of immunoglobulin content of primary central nervous system lymphomas
11. Pharmacology of cytosine arabinoside